Recent studies have demonstrated elevated levels of phosphorylated signal transducer and activator of transcription 3 (pSTAT3), a key regulatory molecule in cell signaling, in circulating myeloid (monocyte/macrophage) cells from patients with diabetes and in STZ-induced diabetic mice (57).. This evidence concerns the gene STAT3 and diabetes mellitus.